|
|
|
Visit Our Website
|
| YM BioSciences Inc. is an oncology company that identifies, develops and commercializes differentiated products for patients worldwide. The Company is advancing two late-stage products: nimotuzumab, a humanized monoclonal antibody that targets the epidermal growth factor receptor (EGFR) and is approved in several countries for treatment of various types of head and neck cancer; and AeroLEF™, a proprietary, inhaled-delivery composition of free and liposome-encapsulated fentanyl in development for the treatment of moderate to severe pain, including cancer pain. |
|
| Address: | 5045 Orbitor Drive, Building 11, Suite 400
Mississauga,
Ontario
L4W 4Y4 |
| Phone: |
(905) 629-9761 |
| Fax: |
(905) 629-4959 |
| Website: |
Visit Our Website
|
|
|
|
 |
|
|
|
|
Search This Site
|
 |
|
|
|
|
|
©1998-2008 NASN Licensing
Inc. All Rights Reserved.  |
|
Find More Stores & Business Services In our Business Directories:
|
|
|
